07:04 AM EST, 11/07/2024 (MT Newswires) -- Oscar Health ( OSCR ) reported Thursday a Q3 loss of $0.22 per diluted share, narrowing from a loss of $0.29 a year earlier.

Analysts polled by Capital IQ expected a GAAP loss of $0.20.

Revenue for the quarter ended Sept. 30 was $2.42 billion, up from $1.44 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.35 billion.

The company said it expects 2024 revenue of $9.2 billion to $9.3 billion, compared with the previous forecast of $9 billion to $9.1 billion. Analysts polled by Capital IQ expect $9.05 billion.

Price: 16.85, Change: -0.19, Percent Change: -1.12